| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/08/2014 | EP2680885A1 Combination vaccines with lower doses of antigen and/or adjuvant |
| 01/08/2014 | EP2680884A2 Biological markers and methods for predicting response to b-cell antagonists |
| 01/08/2014 | EP2680883A1 Pcsk9 vaccine |
| 01/08/2014 | EP2680882A1 Therapeutic cancer vaccine |
| 01/08/2014 | EP2680881A1 Vaccination in elderly patients |
| 01/08/2014 | EP2680880A1 Vaccination in newborns and infants |
| 01/08/2014 | EP2680839A1 Co -administration of eribulin and farletuzumab for the treatment of breast cancer |
| 01/08/2014 | EP2468771A9 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient |
| 01/08/2014 | CN103502439A Method for proliferation of antigen-specific T cells |
| 01/08/2014 | CN103502274A Anti-il-6 receptor antibodies and methods of use |
| 01/08/2014 | CN103502272A Phosphated specific antibody for identifying Tau |
| 01/08/2014 | CN103502264A Peptide which can induce antibody capable of recognizing stereostructure of HIV |
| 01/08/2014 | CN103501820A Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells |
| 01/08/2014 | CN103501816A Chimeric CD27 receptors for redirecting t cells to CD70-positive malignancies |
| 01/08/2014 | CN103501815A A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use |
| 01/08/2014 | CN103501814A Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| 01/08/2014 | CN103501813A Tolerogenic synthetic nanocarriers to reduce antibody responses |
| 01/08/2014 | CN103501812A Tolerogenic synthetic nanocarriers for allergy therapy |
| 01/08/2014 | CN103501811A Compositions and methods for treating viral infections |
| 01/08/2014 | CN103501810A Enhanced immune response in bovine species |
| 01/08/2014 | CN103501809A Vaccines and compositions against streptococcus pneumoniae |
| 01/08/2014 | CN103501808A Composition for immunization against streptococcus pneumoniae |
| 01/08/2014 | CN103501807A Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv |
| 01/08/2014 | CN103501806A Immunomodulatory methods and systems for treatment and/or prevention of aneurysms |
| 01/08/2014 | CN103501787A Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells |
| 01/08/2014 | CN103501786A Tolerogenic synthetic nanocarriers |
| 01/08/2014 | CN103497934A Avian infectious bronchitis virus vaccine strain (HF2 strain) and application thereof |
| 01/08/2014 | CN103497933A Application of H9N2 type avian influenza virus strain in vaccine development |
| 01/08/2014 | CN103497255A Conjugates of plasmodium falciparum surface proteins as malaria vaccines |
| 01/08/2014 | CN103497254A Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 01/08/2014 | CN103495182A Newcastle disease diad vaccine and preparation method thereof |
| 01/08/2014 | CN103495180A Freezing and drying protecting agentCryoprotectant for porcine reproductive and respiratory syndrome compound inactivated vaccine |
| 01/08/2014 | CN103495167A Method for preparing chicken infection bursal disease composite live vaccine |
| 01/08/2014 | CN103495166A Preparation method of complex live vaccine for porcine reproductive and respiratory syndrome |
| 01/08/2014 | CN103495165A Method of administering anti-TNFalpha antibodies |
| 01/08/2014 | CN103495164A Applications of fullerene derivatives, vaccine adjuvant, and vaccine preparation thereof |
| 01/08/2014 | CN103495163A Oil-in-water-in-oil type inactivated vaccine for avian influenza virus and preparation method thereof |
| 01/08/2014 | CN103495162A Preparation method of porcine reproductive and respiratory syndrome compound inactivated vaccine |
| 01/08/2014 | CN103495161A Mixture of poly-pneumococcal capsular polysaccharide-protein conjugates and preparation method of mixture |
| 01/08/2014 | CN103495160A Preparation method of inactivated mycoplasma synoviae vaccine |
| 01/08/2014 | CN103495159A Preparation method of flavobacterium columnare genetic recombination vaccines |
| 01/08/2014 | CN103495158A Specific chronic myelogenous leukemia epitope vaccine for human leukocyte antigen (HLA) of Chinese population |
| 01/08/2014 | CN103495157A DC (Dendritic Cell) vaccine as well as preparation method and application thereof |
| 01/08/2014 | CN103494914A 复方黄芪免疫激活注射液 Compound Astragalus injection of immune activation |
| 01/08/2014 | CN103055310B Bigeminal inactivated vaccine for avian influenza (H9 sub type) and Escherichia coli and preparation method thereof |
| 01/08/2014 | CN102876620B Nontoxic ST28 streptococcus suis and application thereof |
| 01/08/2014 | CN102836428B Inactivated vaccine preparation method for egg yolk antibody for resisting litopenaeus vannamei red body disease |
| 01/08/2014 | CN102807972B Hepatitis A virus purification method |
| 01/08/2014 | CN102755642B Preparing method of anthrax vaccines |
| 01/08/2014 | CN102731616B Tetanus-toxin-neutralizing B cell epitope peptide and application thereof |
| 01/08/2014 | CN102492661B Preparation method and application of immunization preparation for controlling novel duck reovirus |
| 01/08/2014 | CN102399289B Human IgE (immunoglobulin E) Fab (fragment ab) against human and coding gene and application thereof |
| 01/08/2014 | CN101600457B Anti-il-13 antibody formulations and uses thereof |
| 01/08/2014 | CN101565458B Peptide vaccine for animal and preparation method thereof |
| 01/08/2014 | CN101495138B Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 01/08/2014 | CN101432301B Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/08/2014 | CN101031318B Cellular permissivity factor for viruses and uses thereof |
| 01/07/2014 | US8624007 Alteration of Fc-fusion protein serum half-lives by mutagenesis |
| 01/07/2014 | US8624004 Purification of HBV antigens for use in vaccines |
| 01/07/2014 | US8624003 Methods for preparation of antibody-maytansinoid conjugates |
| 01/07/2014 | US8623830 Compositions containing α-1-antitrypsin and methods for use |
| 01/07/2014 | US8623816 Compositions and methods for treating malaria with cupredoxin and cytochrome |
| 01/07/2014 | US8623644 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/07/2014 | US8623609 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents |
| 01/07/2014 | US8623416 Formulations comprising aminosterols |
| 01/07/2014 | US8623397 Delivery device and method for forming the same |
| 01/07/2014 | US8623383 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae |
| 01/07/2014 | US8623382 Immunogenic compositions for inducing an immune response to HIV |
| 01/07/2014 | US8623381 Viral strains derived from the vaccinia virus Lister VACV-107 and uses thereof |
| 01/07/2014 | US8623380 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids |
| 01/07/2014 | US8623379 Compositions and methods for generating an immune response |
| 01/07/2014 | US8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 01/07/2014 | US8623377 Joint-homing peptides and uses thereof |
| 01/07/2014 | US8623376 Chimeric OspA genes, proteins, and methods of use thereof |
| 01/07/2014 | US8623375 Chimeric OspA genes, proteins, and methods of use thereof |
| 01/07/2014 | US8623374 Method for enhancing immune response with peptide |
| 01/07/2014 | US8623373 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 01/07/2014 | US8623372 Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases |
| 01/07/2014 | US8623371 Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections |
| 01/07/2014 | US8623370 Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same |
| 01/07/2014 | US8623369 Anti-ICAM-1 single domain antibody and uses thereof |
| 01/07/2014 | US8623368 Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 01/07/2014 | US8623367 Antibody formulation |
| 01/07/2014 | US8623366 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 01/07/2014 | US8623365 Aβ binding molecules |
| 01/07/2014 | US8623364 Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 01/07/2014 | US8623363 Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections |
| 01/07/2014 | US8623362 Anti-IL-6 antibodies |
| 01/07/2014 | US8623361 Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 01/07/2014 | US8623360 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 01/07/2014 | US8623359 Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/07/2014 | US8623358 Therapeutic DLL4 binding proteins |
| 01/07/2014 | US8623357 Therapeutic antibodies |
| 01/07/2014 | US8623355 Methods for suppressing acute rejection of a heart transplant |
| 01/07/2014 | US8623354 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 01/07/2014 | US8623353 TLR2 antagonistic antibody and use thereof |
| 01/07/2014 | US8623349 Systems, methods and microrganisms for antibody production with type III secretion system |
| 01/07/2014 | US8623348 Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) |
| 01/07/2014 | US8623347 Antiviral drugs for treatment of arenavirus infection |
| 01/07/2014 | CA2570407C Methods and compositions for modulating stem cell growth and differentiation |